Bayer decides against Say on Climate amid ESG backlash
Pharma giant says investors raised 'concerns around timing' as it plans to continue to monitor 'controversy around ESG'.
Pharma giant says investors raised 'concerns around timing' as it plans to continue to monitor 'controversy around ESG'.
Copyright PEI Media
Not for publication, email or dissemination